7-chlorokynurenic acid prevents in vitro epileptiform and neurotoxic effects due to kainic acid

Gen Pharmacol. 1996 Jan;27(1):113-6. doi: 10.1016/0306-3623(95)00124-7.

Abstract

1. The effects of 7-chlorokynurenic acid were studied against the epileptiform and neurotoxic effects due to the non-NMDA excitatory amino acid, kainic acid, in rat hippocampal slices. 2. Slice perfusion with 7-chlorokynurenic acid (100 microM), significantly (p < 0.05) decreased the duration of the CA1 epileptiform bursting due to 1 microM kainic acid. 3. Slice perfusion with 7-chlorokynurenic acid (100 microM) significantly (p < 0.05) increased the probability of recovery of the CA1 population spike after a neurotoxic concentration (12 microM) of kainic acid. 4. The results indicate that 7-chlorokynurenic acid affects, with a similar potency, epileptiform and neurotoxic effects due to kainic acid.

MeSH terms

  • Animals
  • Electrophysiology
  • Epilepsy / chemically induced
  • Epilepsy / prevention & control*
  • Excitatory Amino Acid Agonists* / pharmacology
  • Hippocampus / drug effects
  • In Vitro Techniques
  • Kainic Acid / antagonists & inhibitors*
  • Kainic Acid / pharmacology
  • Kynurenic Acid / analogs & derivatives*
  • Kynurenic Acid / pharmacology
  • Male
  • Rats
  • Rats, Wistar
  • Receptors, N-Methyl-D-Aspartate*

Substances

  • Excitatory Amino Acid Agonists
  • Receptors, N-Methyl-D-Aspartate
  • Kynurenic Acid
  • 7-chlorokynurenic acid
  • Kainic Acid